Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Times Interest Earned (2016 - 2017)

Historic Times Interest Earned for CytomX Therapeutics (CTMX) over the last 4 years, with Q1 2017 value amounting to -$41.82.

  • CytomX Therapeutics' Times Interest Earned rose 878.21% to -$41.82 in Q1 2017 from the same period last year, while for Dec 2017 it was -$224.56, marking a year-over-year decrease of 53652.35%. This contributed to the annual value of -$35.28 for FY2016, which is 8402.85% down from last year.
  • According to the latest figures from Q1 2017, CytomX Therapeutics' Times Interest Earned is -$41.82, which was up 878.21% from -$36.58 recorded in Q4 2016.
  • Over the past 5 years, CytomX Therapeutics' Times Interest Earned peaked at -$13.58 during Q2 2015, and registered a low of -$45.84 during Q1 2016.
  • Moreover, its 4-year median value for Times Interest Earned was -$30.66 (2016), whereas its average is -$30.84.
  • Its Times Interest Earned has fluctuated over the past 5 years, first soared by 4698.86% in 2015, then tumbled by 12573.52% in 2016.
  • Over the past 4 years, CytomX Therapeutics' Times Interest Earned (Quarter) stood at -$42.74 in 2014, then rose by 28.3% to -$30.65 in 2015, then dropped by 19.35% to -$36.58 in 2016, then fell by 14.31% to -$41.82 in 2017.
  • Its Times Interest Earned stands at -$41.82 for Q1 2017, versus -$36.58 for Q4 2016 and -$30.95 for Q3 2016.